(Alliance News) - AstraZeneca PLC on Monday said in won three recommendations for approval for the treatment of adults with cancers in the European Union from the Committee for Medicinal Products for Human Use of the European Medicines Agency. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday: Read More
(Alliance News) - Stocks in London were mostly lower on Monday, though the FTSE 100 was in the green as investors looked ahead to the UK budget statement later in the week, which Chancellor Jeremy Hunt promised to be "rabbit-free". Read More
(Alliance News) - AstraZeneca PLC on Friday said the US Food & Drug Administration has approved its cancer drugs Imfinzi and Imjudo in combination with chemotherapy for the treatment of adults with stage four non-small cell lung cancer. Read More
(Alliance News) - AstraZeneca PLC on Thursday said it was continuing to see the benefit of sustained investment, as it raised its annual guidance on the back of strong results in the year to date. Read More
(Alliance News) - Stocks in Europe struggled early on Thursday, though the FTSE 100 notched a minor gain, as investors held their breath ahead of all-important inflation data from the world's largest economy. Read More
(Alliance News) - Stocks in London are called lower on Thursday, with a stack of UK corporate updates keeping investors busy until the afternoon's eagerly-anticipated US inflation reading. Read More
(Alliance News) - AstraZeneca PLC on Wednesday said it is well-placed to transform current asthma emergency treatment approaches, after its inhaler was recommended by the US Food & Drug Administration. Read More
Beximco Pharmaceuticals Ltd - Dhaka-based generic pharmaceutical products and active pharmaceutical ingredients maker - In the financial year that ended June 30, books pretax profit of BDT6.69 billion, around GBP57.6 million, up 4.9% from BDT6.37 billion a year before. Annual revenue climbs 18% to BDT34.67 billion from BDT29.49 billion, with domestic sales rising by 21% and export sales by 14%. Declares BDT3.5 per share dividend. Read More
(Alliance News) - AstraZeneca PLC on Monday shared more positive data for Farxiga for use in the treatment of heart failure. Read More
(Alliance News) - Stocks were higher in London early Friday, as mining stocks lifted the FTSE 100, buoyed by rumours of an end to China's zero-tolerance Covid policies. Read More
(Alliance News) - AstraZeneca PLC on Friday said its respiratory syncytial virus treatment Beyfortus, or nirsevimab, which it develops with Sanofi SA, has received EU approval for prevention of the virus in newborns and infants. Read More
(Alliance News) - Stock prices in London were called higher on Friday in the wake of US Federal Reserve and Bank of England rate hikes, as markets now await a key US jobs report, expected to show a softening in the labour market. Read More
(Alliance News) - AstraZeneca PLC on Tuesday said its Covid vaccine Vaxzevria won full marketing authorisation in the EU. Read More
(Alliance News) - Stocks in London are set to open in the green on Tuesday, as the US Federal Reserve policy meeting gets underway. Read More
(Alliance News) - AstraZeneca PLC on Monday said it will present new data on cardiovascular and renal disease drugs in the US between Thursday and Monday next week. Read More
(Alliance News) - AstraZeneca PLC on Thursday said phase 3 trial results for its Ultomiris treatment showed a "significant" reduction in the risk of relapse in adults with neuromyelitis optica spectrum disorder. Read More
(Alliance News) - AstraZeneca PLC's Covid vaccine has been linked to a 30% higher risk of getting a very rare blood clotting condition compared to the Pfizer Inc jab, a large international study said Thursday. Read More
(Alliance News) - AstraZeneca PLC on Wednesday said its breast cancer drugs capivasertib and camizestrant significantly improved progression-free survival in a phase 3 and 2 trial respectively. Read More